In 2011, Clinical Proteomics converted from a subscription publication to a fully open access journal. The journal's back content can be viewed on SpringerLink.
Featured meeting: HUPO 2019
The 18th edition of the Human Proteome Organization (HUPO) World Congress will be held from the 15th through the 19th of September, in beautiful Adelaide, Australia. Earlybird registration is ongoing but for more information, please visit the conference website.
Featured article: Current applications of antibody microarrays
The concept of antibody microarrays is one of the most versatile approaches within multiplexed immunoassay technologies. These types of arrays have increasingly become an attractive tool for the exploratory detection and study of protein abundance, function, pathways, and potential drug targets. In spite of the growing number of studies utilizing this technique, few reviews about antibody microarray technology have been presented to reflect the quality and future uses of the generated data. In this review, we provide a summary of the recent applications of antibody microarray techniques in basic biology and clinical studies, providing insights into the current trends and future of protein analysis.
Articles
-
-
The plasma peptides of breast versus ovarian cancer
-
Quantitative proteome analysis of Merkel cell carcinoma cell lines using SILAC
-
Clinical method evaluation of hemoglobin S and C identification by top-down selected reaction monitoring and electron transfer dissociation
-
The associations of self-rated health with cardiovascular risk proteins: a proteomics approach
Archival content
Trezvuy - Fotolia
Have an idea for a new thematic series?
Make a suggestion here
Aims and scope
Clinical Proteomics encompasses all aspects of translational proteomics. Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. The journal is committed to rapid scientific review and timely publication of submitted manuscripts.
Editor's profile
Dr Daniel W Chan is currently Professor of Pathology, Oncology, Urology, and Radiology at Johns Hopkins Medical Institutions, and Director of the Clinical Chemistry Division, Co-Director at the Pathology Core Laboratory, and Director at the Center for Biomarker Discovery and Translation at the Johns Hopkins University School of Medicine. He has worked extensively on the development and application of proteomic and immunologic techniques in the understanding of cancer. As the author of five books and over 300 articles, Dr Chan has become established as a leading expert in clinical proteomics and cancer research. Dr Chan is an active member of US Human Proteome Organization (USHUPO), American Association for Cancer Research (AACR) and American Association for Clinical Chemistry (AACC).
Featured collections
PediOme
Guest edited by Vera Ignjavtovic, Allen Everett and Hanno Steen
The Paediatric Proteomics (PediOme) is an initiative of HUPO that aims to advance the use of proteomic techniques to solve major issues in Paediatric medicine.
Proteomics in India
Guest edited by Harsha Gowda and Akhilesh Pandey
This collections features the latest advances in Proteomics research from India.
Glycoproteomics and glycomics
Guest edited by Punit Shah and Hui Zhang
This thematic series publishes both solicited and unsolicited content on the topic of protein glycosylation; one of the most common protein modifications in both normal biological processes and diseases. This series focuses on glycoproteomic or glycomic methods and their clinical applications.
Advertisement
-
Affiliated with
-
Clinical Proteomics is affiliated with the Human Proteome Organization (HUPO). HUPO is an international scientific organization representing and promoting proteomics through international cooperation and collaborations by fostering the development of new technologies, techniques and training.
-
- Editorial Board
- Sign up for article alerts and news from this journal
Annual Journal Metrics
-
Speed
72 days to first decision for reviewed manuscripts only
64 days to first decision for all manuscripts
141 days from submission to acceptance
13 days from acceptance to publication
Citation Impact
2.892 - 2-year Impact Factor
3.440 - 5-year Impact Factor
0.857 - Source Normalized Impact per Paper (SNIP)
0.897 - SCImago Journal Rank (SJR)
Usage
126,623 downloads
129 Altmetric mentions
Advertisement
